News & Resources

Current and relevant information for our customers

In the News

NCCN

March 31-April 2, 2022
Join us at the National Comprehensive Cancer Network® 2022 Annual Conference virtual event.

Set up a time to meet.

ONS

April 27-May 1, 2022
Mark your calendar and visit us at the 47th Annual Oncology Nursing Society Congress in Anahein, CA.

Set up a time to meet.

sPCMA

February 28-March 3, 2022
Join us at the 2022 Specialty Pharmaceutical Care Management Business Forum in Orlando, FL.

Set up a time to meet.

ACCC

March 2-4, 2022
Join us at the ACCC 48th Annual Meeting & Cancer Center Business Summit in Washington, D.C.

Set up a time to meet.

COA

March 17-18, 2022
Visit us in booth #111 at the Community Oncology Alliance Annual Meeting in Kissimmee, FL.

Set up a time to meet.

HOPA

March 30-April 2, 2022
Visit us in booth #712 at the 2022 Hematology/Oncology Pharmacy Association Annual Conference in Boston, MA.

Set up a time to meet.

At the forefront of health care innovation

Fresenius Kabi develops reliable, high-quality biosimilars for autoimmune diseases and oncology. Learn how we as a global health care company are at the forefront of health care innovation and patient care.

Providing Affordable Medicines

Fresenius Kabi: Caring for Life

What biosimilars means to me

Fresenius Kabi is a member of the Biosimilars Council

The Biosimilars Council works to ensure a positive regulatory, reimbursement, political and policy environment for biosimilar products. The council educates the public and patients about the safety and effectiveness of biosimilars, focusing on access, the regulatory environment, reimbursement and legal affairs.

Biosimilars Council Resources

(Please note: Fresenius Kabi is not responsible for the content of third-party websites.)

Info

Looking for more information?

If you would like to know more about Fresenius Kabi and our unique approach to biosimilars, please get in touch.

Contact Us
Fresenius Kabi

Fresenius Kabi AG ┬ę June 2021 1702-BIOS-08-05/21